Liquidia (NASDAQ:LQDA) CAO Sells $140,048.00 in Stock

Liquidia Corporation (NASDAQ:LQDA) CAO Dana Boyle sold 1,600 shares of the firm’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $87.53, for a total transaction of $140,048.00. Following the completion of the sale, the chief accounting officer directly owned 167,919 shares in the company, valued at approximately $14,697,950.07. This trade represents a 0.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dana Boyle also recently made the following trade(s):

• On Monday, July 13th, Dana Boyle sold 9,002 shares of Liquidia stock. The stock was sold at an average price of $71.51, for a total transaction of $643,733.02.

Liquidia Trading Down 3.1%

NASDAQ LQDA opened at $84.11 on Friday. The company has a quick ratio of 2.03, a current ratio of 2.22 and a debt-to-equity ratio of 1.18. Liquidia Corporation has a 52 week low of $16.82 and a 52 week high of $91.10. The stock has a market capitalization of $7.48 billion, a PE ratio of 600.83 and a beta of 0.55. The firm has a 50 day moving average of $73.77 and a two-hundred day moving average of $51.95.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings data on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The company had revenue of $132.87 million for the quarter, compared to the consensus estimate of $119.44 million. Liquidia’s quarterly revenue was up 4187.1% on a year-over-year basis. As a group, research analysts expect that Liquidia Corporation will post 3.02 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Farallon Capital Management LLC grew its position in shares of Liquidia by 1.1% in the 4th quarter. Farallon Capital Management LLC now owns 8,656,038 shares of the company’s stock valued at $298,547,000 after buying an additional 90,400 shares during the last quarter. Vanguard Group Inc. lifted its position in Liquidia by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company’s stock valued at $138,439,000 after acquiring an additional 52,671 shares during the last quarter. Opaleye Management Inc. lifted its position in Liquidia by 9.5% in the second quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company’s stock valued at $30,838,000 after acquiring an additional 215,000 shares during the last quarter. Bank of America Corp DE lifted its position in Liquidia by 18.7% in the first quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock valued at $86,341,000 after acquiring an additional 360,372 shares during the last quarter. Finally, Caprock Group LLC boosted its stake in Liquidia by 9.3% in the fourth quarter. Caprock Group LLC now owns 1,783,921 shares of the company’s stock valued at $61,527,000 after acquiring an additional 151,832 shares in the last quarter. Institutional investors and hedge funds own 64.54% of the company’s stock.

Analyst Upgrades and Downgrades

LQDA has been the topic of several recent analyst reports. Jefferies Financial Group reissued a “buy” rating and issued a $60.00 target price on shares of Liquidia in a report on Monday, May 11th. Piper Sandler set a $129.00 price target on Liquidia in a report on Friday, July 24th. Needham & Company LLC upped their price objective on Liquidia from $54.00 to $70.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Zacks Research upgraded Liquidia from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Finally, Wells Fargo & Company raised their target price on Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. Three equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $86.18.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).